Executive Summary
This digest covers a single $98.8M civilian contract from the Department of Homeland Security (DHS) to Leidos, Inc., representing 100% of the period's total obligation. The contract is for low-energy non-intrusive inspection systems for Customs and Border Protection (CBP), a firm-fixed-price delivery order with options extending to 2033.
The highest-conviction signal is neutral: the award signals stable border security technology spending and Leidos' execution capability, but the long duration, 22% subaward concentration, and fixed-price risk temper the bullish case. Key risk is DHS budget appropriations for border technology, which could affect option exercise or renewal beyond 2027.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior DHS Homeland Security Contracts digest from May 18, 2026.
Investment Signals (2)
- Leidos Secures $98.8M DHS Border Inspection Contract with Long-Term Recurring Revenue (MEDIUM)▲
Leidos won a $98.8M firm-fixed-price delivery order from DHS/CBP for irradiation-based inspection systems, with options extending to 2033. The full-and-open competition win and high barriers to entry in irradiation apparatus manufacturing suggest a competitive moat in border security technology.
- Fixed-Price Structure and 22% Subaward Concentration Add Execution Risk for Leidos (MEDIUM)▲
The firm-fixed-price pricing shifts cost overrun risk to Leidos, while 22% of the contract value is subawarded, introducing potential subcontractor performance issues. Annual revenue contribution is modest (~$16.5M) relative to Leidos' overall portfolio.
Risk Flags (3)
- Budget [MEDIUM RISK]▼
DHS budget appropriations for border security technology are subject to annual Congressional approval; a Continuing Resolution or budget cuts could delay or cancel option years beyond 2027.
- Execution [MEDIUM RISK]▼
22% subaward concentration means nearly $22M of work is performed by subcontractors, creating potential delivery delays or quality issues that Leidos must manage under a fixed-price contract.
- Concentration [LOW RISK]▼
This single contract represents 100% of the period's total obligation, indicating no diversification across multiple awards for the period. However, this is a single-day snapshot, not a trend.
Opportunities (2)
- ◆
Option years extending to 2033 provide Leidos with a long-term recurring revenue stream for border inspection systems, with potential for additional task orders under the same IDIQ vehicle.
- ◆
DHS/CBP's investment in non-intrusive inspection technology signals sustained demand for radiation-based border security systems, benefiting Leidos and other suppliers like Rapiscan Systems or Smiths Detection.
Sector Themes (1)
- ◆
This $98.8M DHS contract for irradiation-based inspection systems underscores ongoing federal investment in non-intrusive border security technology, a civilian priority distinct from defense spending.
Watch List (2)
- 👁
{"entity"=>"Leidos, Inc.", "reason"=>"This contract contributes ~$16.5M annual revenue to Leidos' civilian segment; option exercises and modifications will indicate DHS commitment to border technology.", "trigger"=>"Option exercise announcement beyond 2027; Leidos Q3 2026 earnings call for contract performance update"}
- 👁
{"entity"=>"DHS/CBP border security technology sector", "reason"=>"Sustained investment in non-intrusive inspection systems suggests stable demand; any budget cuts would be a bearish signal for Leidos and peers.", "trigger"=>"FY2027 DHS budget request release (expected Feb 2026); NDAA border security provisions"}
Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: DHS Homeland Security Contracts
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals